Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8302 | 0.84 | XDH (0.39) | XDHGAAALDH1A1 | |
| SCHEMBL523465 | 0.84 | XDH (0.47) | XDHALDH1A1 | |
| Pyrimidine SCHEMBL28141456 | 0.81 | XDH (0.36) | XDHGAAALDH1A1 | |
| SCHEMBL27838826 | 0.79 | BLM (0.34) | FDPSALDH1A1 | |
| SCHEMBL1445604 | 0.77 | ALDH1A1 (0.33) | XDHGAAALDH1A1 | |
| SCHEMBL1031449 | 0.77 | FDPS (0.43) | FDPSALDH1A1 | |
| SCHEMBL6036330 | 0.75 | CDK1 (0.44) | FDPS | |
| SCHEMBL2120550 | 0.74 | FDPS (0.45) | FDPSALDH1A1 | |
| SCHEMBL851861 | 0.73 | FDPS (0.32) | FDPS | |
| SCHEMBL852593 | 0.73 | HSP90AB1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023198082-A1 | NON-LINEAR PEGYLATED LIPID AND APPLICATION THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2023-10-19 | — | — | WO | disclosed |
| WO-2023198084-A1 | NITROGEN-BRANCHED NONLINEAR PEGYLATED LIPID AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2023-10-19 | — | — | WO | disclosed |
| WO-2023198083-A1 | NONLINEAR PEGYLATED LIPID CONTAINING TERTIARY AMINE AND APPLICATION THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2023-10-19 | — | — | WO | disclosed |
| WO-2023126006-A1 | CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2023-07-06 | — | — | WO | disclosed |
| CN-112912395-A | anti-GDF 15 antibodies, compositions, and methods of use | 辉瑞公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-112469418-A | Dosing regimens for treating PI3K related disorders | 因赛特公司 | 2021-03-09 | — | — | CN | disclosed |
| CN-112004848-A | Block copolymers and self-assembled nanoparticles formed therefrom | 国际商业机器公司 | 2020-11-27 | — | — | CN | disclosed |
| CN-104520290-B | Amido spirocyclic amide and sulfonamide derivatives | 基因科技股份有限公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-103717263-B | Antibodies that bind OX40 and uses thereof | 格兰马克药品股份有限公司 | 2018-01-12 | — | — | CN | disclosed |
| CN-103930442-B | Anti-CD 40 antibodies, purposes and method | 鳄鱼生物科学公司 | 2017-09-26 | — | — | CN | disclosed |
| EP-1793830-A2 | THERAPEUTIC COMBINATIONS COMPRISING POLY(ADP-RIBOSE) POLYMERASES INHIBITOR | Pfizer, Inc. (US) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006033006-A2 | THERAPEUTIC COMBINATIONS COMPRISING POLY(ADP-RIBOSE) POLYMERASES INHIBITOR | PFIZER INC., (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-0254268-A2 | Fluorinated nucleosides,their preparation and their pharmaceutical use against AIDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-01-27 | — | — | EP | disclosed |